DYN
Price
$19.27
Change
-$0.15 (-0.77%)
Updated
Dec 12 closing price
Capitalization
3.12B
75 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DYN

Header iconDYN Comparison
Open Charts DYNBanner chart's image
Dyne Therapeutics
Price$19.27
Change-$0.15 (-0.77%)
Volume$4.45M
Capitalization3.12B
DYN Comparison Chart in %
DYN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.21B. The market cap for tickers in the group ranges from 58 to 114.69B. VRTX holds the highest valuation in this group at 114.69B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 65%. NBY experienced the highest price growth at 158%, while BPTSY experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was 72%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 80
Price Growth Rating: 54
SMR Rating: 92
Profit Risk Rating: 93
Seasonality Score: 17 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (DYN: $19.42)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green while.

  • DYN’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 5 TA indicator(s) are bullish.

  • DYN’s TA Score: 5 bullish, 3 bearish.

Price Growth

DYN (@Biotechnology) experienced а -5.96% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

DYN is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN
Capitalization3.12B
EBITDA-445.29M
Gain YTD-17.572
P/E RatioN/A
Revenue0
Total Cash792M
Total Debt120M
TECHNICAL ANALYSIS
Technical Analysis
DYN
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 5 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Declines
ODDS (%)
Bearish Trend 24 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 5 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VADGX31.690.30
+0.96%
Vanguard Advice Select Dividend Gr Admrl
AGCWX20.100.19
+0.95%
American Century Global Small Cap R
MGICX39.410.35
+0.90%
MFS International Intrinsic Value C
LSCNX24.260.21
+0.87%
Loomis Sayles Small Cap Value N
PAECX20.770.06
+0.29%
Putnam Dynamic Asset Allocation Gr C

DYN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-1.37%
RNA - DYN
62%
Loosely correlated
+0.35%
SYRE - DYN
55%
Loosely correlated
-0.87%
IDYA - DYN
55%
Loosely correlated
-0.24%
XNCR - DYN
54%
Loosely correlated
-0.58%
NRIX - DYN
50%
Loosely correlated
-2.75%
More